Altogether, ARP101 treatment may result in a feedback loop via the noncanonical Keap1-Nrf2 signaling pathway, which is responsible for increased levels of p62 despite increased LC3 II levels later during infection. This evidence concerns the gene MAP1LC3A and infection.